桑葉萃取物 Mulberry Leaf Extract
B 1 C 1 U 1
適應症與證據等級
法規與權威立場 (L4)
L4a · US FDA
立場:cautious
L4b · EU EFSA
立場:not_addressed
A cause and effect relationship cannot be established between the consumption of Morus alba (white mulberry) leaf extract and the claimed effect. The mulberry extract is not sufficiently characterised in relation to the claimed effect. The proposed target population of diabetic patients does not comply with the criteria for disease risk reduction claims.
來源 ↗ L4c · UK NHS
立場:not_addressed
L4d · TW TFDA / 衛福部
立場:supportive
本產品經動物實驗結果證實:有助於延緩飯後血糖上升,僅供參考。本產品經動物實驗結果證實:有助於降低體脂肪形成(不易形成體脂肪),僅供參考。
來源 ↗ L4e · WHO
立場:not_addressed
市場與行銷 (L10)
L10a · TW Market Channels
桑葉萃取膠囊 NT$1,280
L10b · TW Legal Identity (TFDA)
對於食品所為之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形。食品不得為醫療效能之標示、宣傳或廣告。
L10c · TW Community (PTT/Dcard/Mobile01)